Relationship between residual gastric content and peri-operative semaglutide use assessed by gastric ultrasound: a prospective observational study
Oral semaglutide works by activating GLP-1 receptors in the brain, reducing hunger, and promoting a sense of fullness, while also slowing gastric emptying to prolong satiety
Ingredienti Edulcoranti: mannitolo, sucralosio, neoesperidina, glutatione ridotto, agenti antiagglomeranti: biossido di silicio, polivinilpirrolidone, sali di magnesio degli ascidi grassi, polietilenglicole, vitamina C (acido L-ascorbico), L-cistina, agente di carica: cellulosa, agente antiagglomerante: acidi grassi, L-selenometionina, aromi
doi: 10.3389/fnut.2026.1804917 Received 05 February 2026 Revised 04 March 2026 Accepted 16 March 2026 Published 31 March 2026 Volume 13 - 2026 Edited by Berenice M Romn Calleja, National Institute of Medical Sciences and Nutrition Salvador Zubirn, Mexico Reviewed by Anindita Banerjee, Indian Council of Medical Research (ICMR), India Venkateswararao Eeda, University of Oklahoma Health Sciences Center, United States Updates Copyright 2026 Chen, Zou, Li, Liu, Liu, Yao, Peng, Liang, Chen, Huang and Huang
Glutathione protects neurons but does not have the same neurotransmitter effects
Glu9 of the GLP-1 forms a direct hydrogen bond with Tyr152, an ionic interactions with Arg190, and a water mediated hydrogen bond with Tyr241